Author:
Lu Kai,Feng Feiling,Yang Yingcheng,Liu Kai,Duan Jicheng,Liu Hu,Yang Jiahe,Wu Mengchao,Liu Chen,Chang Yanxin
Funder
National Natural Science Foundation of China
Publisher
Springer Science and Business Media LLC
Reference40 articles.
1. Wu XS, Shi LB, Li ML, et al. Evaluation of two inflammation-based prognostic scores in patients with resectable gallbladder carcinoma. Ann Surg Oncol. 2014;21:449–57.
2. Rakić M, Patrlj L, Kopljar M, et al. Gallbladder cancer Hepatobiliary Surg Nutr. 2014;3:221–6.
3. Li Z, Rana TM. Therapeutic targeting of microRNAs: current status and future challenges. Nat Rev Drug Discov. 2014;13:622–38.
4. Zhang X, Zhang H. Diminished miR-613 expression as a novel prognostic biomarker for human ovarian cancer. Eur Rev Med Pharmacol Sci. 2016;20:837–41.
5. Peng HH, Zhang YD, Gong LS, et al. Increased expression of microRNA-335 predicts a favorable prognosis in primary gallbladder carcinoma. OncoTargets Ther. 2013;6:1625–30.
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献